Journal of Molecular Neuroscience

, Volume 48, Issue 1, pp 53–65

Mitogen-Activated Protein Kinase Pathways are Involved in the Upregulation of Calcitonin Gene-Related Peptide of Rat Trigeminal Ganglion After Organ Culture

Article

Abstract

The trigeminal ganglion (TG) can express and release calcitonin gene-related peptide (CGRP), an important neuropeptide that plays a crucial role in migraine attack and cluster headache. Activation of rat TG increases CGRP expression. However, the regulatory mechanism of CGRP expression in TG neurons remains to be explored. This study aims to evaluate the involvement of mitogen-activated protein kinase (MAPK) pathways in CGRP upregulation after rat TG organ culture. Rat TG was cultured alone for 24 h or cultured in combination with MAPK inhibitors, tumor necrosis factor α (TNF-α), or interleukin 1β (IL-1β) for 24 h. CGRP protein was determined using immunohistochemistry. The mRNA levels of CGRP, TNF-α, and IL-1β were analyzed through real-time quantitative polymerase chain reaction. MAPK phosphorylation was detected via western blot. After rat TG organ culture, the expressions of CGRP, TNF-α, and IL-1β were upregulated at 24 h. The phosphorylation of extracellular signal-regulated kinases (ERK1/2), P38, and c-jun N-terminal kinases (JNK) significantly increased at 30 min compared with fresh rat TG. In addition, both CGRP expression and phosphorylation of ERK1/2, P38, and JNK were enhanced obviously after rat TG treatment with TNF-α or IL-1β compared with fresh rat TG. However, they decreased markedly after rat TG pretreatment with PD98059 (ERK1/2 inhibitor), SB203580 (P38 inhibitor), or SP600125 (JNK inhibitor) compared with rat TG co-culture with TNF-α or IL-1β. In conclusion, the elevated CGRP expression after rat TG organ culture can be regulated via MAPK pathways. The findings provide insight into the molecular mechanisms and experimental evidence for therapeutic targets of migraine.

Keywords

ERK1/2 P38 JNK Neurons TNF-α IL-1β 

Abbreviations

CGRP

Calcitonin gene-related peptide

ERK1/2

Extracellular signal-regulated kinases 1/2

IL-1β

Interleukin 1β

JNK

c-Jun N-terminal kinases

MAPK

Mitogen-activated protein kinases

P38

P38 protein

TG

Trigeminal ganglion

TNF-α

Tumor necrosis factor α

References

  1. Alessandro C, Alice DC, Lucia L, Giuseppe T, Navarra P, Russo CD (2009) Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 5:30–43CrossRefGoogle Scholar
  2. Barbin G, Roisin MP, Zalc B (2001) Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons. Neurochem Res 26:107–112PubMedCrossRefGoogle Scholar
  3. Basbaum AI, Bautista DM, Scherrer G, Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139:267–284PubMedCrossRefGoogle Scholar
  4. Boćkowski L, Sobaniec W, Beata ZR (2009) Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 41:17–21PubMedCrossRefGoogle Scholar
  5. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663–675PubMedCrossRefGoogle Scholar
  6. Bowen EJ, Schmidt TW, Firm CS, Russo AF, Durham PL (2006) Tumor necrosis factor-α stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem 96:65–77PubMedCrossRefGoogle Scholar
  7. Ceruti S, Villa G, Fumagalli M et al (2011) Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 knock-in mice: implications for basic mechanisms of migraine pain. J Neurosci 31:3638–3649PubMedCrossRefGoogle Scholar
  8. Chang F, Steelman LS, Lee JT et al (2003) Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17:1263–1293PubMedCrossRefGoogle Scholar
  9. Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V, Shi X (2001) Opposite effect of NF-κB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem 276:11414–11419PubMedCrossRefGoogle Scholar
  10. Deverman BE, Patterson PH (2009) Cytokines and CNS development. Neuron 64:61–78PubMedCrossRefGoogle Scholar
  11. Dubov P, Jancalek R, Klusakova I, Svizenska I, Pejchalova K (2006) Intra- and extraneuronal changes of immunofluorescence staining for TNF-α and TNFR1 in the dorsal root ganglia of rat peripheral neuropathic pain models. Cell Mol Neurobiol 26:1205–1217Google Scholar
  12. Edvinsson L (2003) New therapeutic target in primary headaches—blocking the CGRP receptor. Expert Opin Ther Targets 7:377–383PubMedCrossRefGoogle Scholar
  13. Edvinsson L (2004) Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 24:611–622PubMedCrossRefGoogle Scholar
  14. Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, Edvinsson L (2010) Differential distribution of calcitonin gene-related peptide (CGRP) and CGRP receptor components (CLR and RAMP1) in the human trigeminal ganglion. Neuroscience 169:683–696PubMedCrossRefGoogle Scholar
  15. Fidan I, Yuksel S, Ymir T, Irkec C, Nur Aksakal F (2006) The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 171:184–188PubMedCrossRefGoogle Scholar
  16. Gao YJ, Ji RR (2008) Activation of JNK pathway in persistent pain. Neurosci Lett 437:180–183PubMedCrossRefGoogle Scholar
  17. Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193–196PubMedCrossRefGoogle Scholar
  18. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine—current understanding and treatment. N Engl J Med 346:257–270PubMedCrossRefGoogle Scholar
  19. Hanani M (2005) Satellite glial cells in sensory ganglia: from form to function. Brain Res Rev 48:457–476PubMedCrossRefGoogle Scholar
  20. Hardingham GE, Arnold FJ, Bading H (2001) Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci 4:261–267PubMedCrossRefGoogle Scholar
  21. Impey S, Obrietan K, Storm DR (1999) Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23:11–14PubMedCrossRefGoogle Scholar
  22. Jansen-Olesen I, Zhou MF, Znick T, Xu C, Edvinsson L (2005) Expression of inducible nitric oxide synthase in trigeminal ganglion cells during culture. Basic Clin Pharmacol Toxicol 97:355–363PubMedCrossRefGoogle Scholar
  23. Ji RR (2004) Peripheral and central mechanisms of inflammatory pain, with emphasis on MAPkinases. Curr Drug Targets Inflamm Allergy 3:299–303PubMedCrossRefGoogle Scholar
  24. Ji RR, Samad TA, Jin SX (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57–68PubMedCrossRefGoogle Scholar
  25. Jin SX, Zhuang ZY, Woolf CJ (2003) p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23:4017–4022PubMedGoogle Scholar
  26. Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J, Szolcsanyi J, Vitrai J, Bagdy G (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461–470PubMedCrossRefGoogle Scholar
  27. Kawasaki Y, Xu ZZ, Wang X et al (2008) Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14:331–336PubMedCrossRefGoogle Scholar
  28. Kristiansen KA, Edvinsson L (2010) Neurogenic inflammation: a study of rat trigeminal ganglion. J Headache Pain 11:485–495PubMedCrossRefGoogle Scholar
  29. Kumar S, Boehm J, Lee JC (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2:717–726PubMedCrossRefGoogle Scholar
  30. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156–160PubMedCrossRefGoogle Scholar
  31. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54–61PubMedCrossRefGoogle Scholar
  32. Latremoliere A, Woolf CJ (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10:895–926PubMedCrossRefGoogle Scholar
  33. Lee HL, Lee KM, Son SJ, Hwang SH, Cho HJ (2004) Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 15:2807–2811PubMedGoogle Scholar
  34. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF (2008) Calcitonin receptor-like receptor (CLR), receptor activity modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277–1299PubMedCrossRefGoogle Scholar
  35. Mulderry P, Ghatei M, Spokes R, Jones PM, Pierson AM, Hamid QA (1988) Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 25:195–205PubMedCrossRefGoogle Scholar
  36. Neeb L, Hellen P, Boehnke C, Hoffmann J, Schuh-Hofer S, Dirnagl U, Reuter U (2011) IL-1β stimulates COX-2 dependent PGE2 synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One 6:e17360PubMedCrossRefGoogle Scholar
  37. Obata K, Yamanaka H, Kobayashi K (2004) Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci 24:10211–10222PubMedCrossRefGoogle Scholar
  38. Olesen J, Diener HC, Husstedt IW et al (2004) Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS for the acute treatment of migraine. N Engl J Med 350:1104–1110PubMedCrossRefGoogle Scholar
  39. Olesen IJ, Zhou MF, Znick T, Xu CB, Edvinsson L (2005) Expression of inducible nitric oxide synthase in trigeminal ganglion cells during culture. Basic Clin Pharmacol Toxicol 97:355–363CrossRefGoogle Scholar
  40. Raingeaud J, Gupta S, Rogers JS et al (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420–7426PubMedCrossRefGoogle Scholar
  41. Ren K, Torres R (2009) Role of interleukin-1beta during pain and inflammation. Brain Res Rev 60:57–64PubMedCrossRefGoogle Scholar
  42. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129–135PubMedCrossRefGoogle Scholar
  43. Rossum DV, Hanisch UK, Quirion R (1997) Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21:649–678PubMedCrossRefGoogle Scholar
  44. Ruohonen S, Khademi M, Jagodic M, Taskinen HS, Olsson T, Roytta M (2005) Cytokine responses during chronic denervation. J Neuroinflammation 18:26–37CrossRefGoogle Scholar
  45. Rygiel TP, Mertens AE, Strumane K, Kammen R, Collard JG (2008) The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation. J Cell Sci 121:1183–1192PubMedCrossRefGoogle Scholar
  46. Schaeffer HJ, Weber MJ (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435–2444PubMedGoogle Scholar
  47. Schafers M, Geis C, Svensson CI, Luo ZD, Sommer C (2003) Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci 17:791–804PubMedCrossRefGoogle Scholar
  48. Tajti J, Kuris A, Vécsei L, Xu CB, Edvinsson L (2011) Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2. Cephalalgia 31:95–105PubMedCrossRefGoogle Scholar
  49. Takeda M, Tanimoto T, Kadoi J, Nasu M, Takahashi M, Kitagawa J (2007) Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation. Pain 129:155–166PubMedCrossRefGoogle Scholar
  50. Thalakoti S, Patil VV, Damodaram S et al (2007) Neuron–glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 47:1008–1123PubMedCrossRefGoogle Scholar
  51. Troconiz IF, Wolters JM, Tillmann C, Schaefer HG, Roth W (2006) Modelling the anti-migraine effects of BIBN 4096 BS: a new calcitonin gene-related peptide receptor antagonist. Clin Pharmacokinet 45:715–728PubMedCrossRefGoogle Scholar
  52. Turjanski A, Vaque J, Gutkind J (2007) MAP kinases and the control of nuclear events. Oncogene 26:3240–3253PubMedCrossRefGoogle Scholar
  53. Uceyler N, Tscharke A, Sommer C (2007) Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun 21:553–560PubMedCrossRefGoogle Scholar
  54. Widmann C, Gibson S, Jarpe MB, Johnson GL (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143–180PubMedGoogle Scholar
  55. Zhuang S, Demirs JT, Kochevar IE (2000) p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J Biol Chem 275:25939–25948PubMedCrossRefGoogle Scholar
  56. Zhuang ZY, Xu H, Clapham DE, Ji R-R (2004) Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 24:8300–8309PubMedCrossRefGoogle Scholar
  57. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109–110PubMedCrossRefGoogle Scholar
  58. Zimmermann K, Reeh PW, Averbeck B (2002) ATP can enhance the proton induced CGRP release through P2Y receptors and secondary PGE2 release in isolated dura mater. Pain 97:259–265PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Genetics and Molecular Biology, Key Laboratory of Environment and Genes Related to Diseases, Ministry of EducationXi’an Jiaotong University College of MedicineXi’anPeople’s Republic of China
  2. 2.Department of NeurologyThe First Affiliated Hospital of Xi’an Jiaotong University College of MedicineXi’anPeople’s Republic of China
  3. 3.Department of Epidemiology and Medical Statistics, School of Public HealthXi’an Jiaotong University College of MedicineXi’anPeople’s Republic of China

Personalised recommendations